Company / AR per Share
Intellia Therapeutics, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.09
FY2025
5-year range
$0.03 / $0.42
FY2021-FY2025
Trend
+1.3%
vs FY2024
Sector context
#138 of 141
Health Care
What the data says
Among 141 Health Care companies, Intellia Therapeutics, Inc. is in the bottom 2% for ar per share. AR per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2021 to $0.42 in FY2023.
Based on SEC 10-K filings.
0.09 in FY2025 with a 5-year CAGR of +16.9%.
Declined from $0.42 to $0.09 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +22.4%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 141This company $0.09 Sector average $11.78
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 1.3% year-over-year.
- Ranks #138 out of 141 companies in the Health Care sector.
- Peak ar per share was recorded in FY2023.
- Lowest ar per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | +1.3% |
| FY2024 | $0.09 | -78.1% |
| FY2023 | $0.42 | +727.4% |
| FY2022 | $0.05 | +65.0% |
| FY2021 | $0.03 | -27.7% |
| FY2020 | $0.04 | -58.5% |
| FY2019 | $0.10 | -42.6% |
| FY2018 | $0.18 | -38.8% |
| FY2017 | $0.29 | +0.1% |
| FY2016 | $0.29 | -92.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026